← All indications
Pre-Eclampsia
A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
Drugs by status
Approved for this indication (3)
Phase 4 trials (28)
- metformin
- ringer's lactate
- phenylephrine
- hydroxyprogesterone
- vitamin d3
- nitroglycerin
- captopril
- ibuprofen
- nifedipine
- calcium
- albumin (Human)
- ephedrine
- labetalol
- phentolamine mesylate
- acetaminophen
- levobupivacaine
- acetylsalicylic acid
- clonidine
- furosemide
- azithromycin
- dapagliflozin
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- sodium chloride
- sugammadex
- esomeprazole
- methyldopa
- dalteparin
- remifentanil
Phase 3 trials (27)
- vitamin e
- oxytocin
- carbetocin
- progesterone
- enalapril
- folic acid
- hydroxychloroquine
- hydralazine
- levetiracetam
- citrulline
- metaraminol
- nicardipine
- vitamin c
- atorvastatin
- ropivacaine
- pravastatin
- lidocaine
- enoxaparin
- uropidil
- dexmedetomidine
- sildenafil
- hydrochlorothiazide
- misoprostol
- antithrombin iii (human)
- docosahexaenoic acid
- ubiquinone
- arginine
Phase 2 trials (14)
Phase 1 trials (12)
Organizations
Organization Involved with Phase 4 Indications (44)
- Octapharma
- Gynuity Health Projects
- Vastra Gotaland Region
- Maastricht University
- University of Pittsburgh
- Ain Shams University
- Albany Medical College
- Cairo University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Harvard University
- Duke University
- Guangzhou Medical University
- Kocaeli University
- Maimonides Medical Center
- Mansoura University
- Ohio State University
- Radboud University
- University of Michigan
- University of New Mexico
- University of Southern California
- University of Tennessee
- Assiut University
- Istanbul University
- Laval University
- Peking University
- Royal College of Surgeons, Ireland
- Stony Brook University
- University of British Columbia
- University of Chicago
- Icahn School of Medicine at Mount Sinai
- +14 more
Organization Involved with Phase 3 Indications (67)
- Kyowa Hakko Kirin
- Japan Blood Products Organization
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Center for Complementary and Integrative Health (NCCIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Dental and Craniofacial Research (NIDCR)
- Complejo Hospitalario Dr. Arnulfo Arias Madrid
- University of Pennsylvania
- Medical University of Graz
- Baylor University
- Benha University
- Case Western Reserve University
- Centre Hospitalier Intercommunal Creteil
- University of London
- Cornell University
- Dow University of Health Sciences
- Federal University of Rio Grande do Sul
- Ghana Health Services
- Hawaii Pacific Health
- Hospital Civil Juan I. Menchaca
- Oregon Health and Science University
- RTI International
- Saint Thomas Hospital, Panama
- Services Institute of Medical Sciences, Pakistan
- University of Ghana
- University of Liverpool
- University of Ottawa
- Utrecht University
- Yale University
- +37 more
Organization Involved with Phase 2 Indications (23)
- BTG
- Pfizer
- Novartis
- GlaxoSmithKline
- Velo Bio, LLC
- Hormozgan University of Medical Sciences
- King Fahad Medical City
- Showa University
- Thomas Jefferson University
- University of Guadalajara
- University of Kentucky
- University of Manchester
- Virginia Commonwealth University
- Wake Forest University
- William Marsh Rice University
- Columbia University
- University of Indonesia
- University of Malawi
- Isfahan University
- University of North Carolina at Chapel Hill
- Washington University in St. Louis
- March of Dimes
- Airlangga University
Organization Involved with Phase 1 Indications (12)
Organization Involved with Other Experimental Indications (42)
- Bayer
- National Center for Research Resources (NCRR)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- United States Army
- Aarhus University
- Gadarif University
- Jawaharlal Nehru Medical College
- Medical College of Wisconsin
- Minia University
- Stanford University
- Sichuan University
- University of Oulu
- University of Southern Denmark
- University of Tampere
- Zagazig University
- Aga Khan University
- Chinese University of Hong Kong
- Chongqing Medical University
- Municipal Hospital Vila Nova Cachoeirinha
- University of Nairobi
- University of Utah
- Uppsala University
- Zhejiang University
- Food and Drug Administration
- Emek Medical Center
- John Snow, Inc.
- Technion University
- Maternidade Escola de Vila Nova Cachoeirinha
- Rajavithi Hospital, Bangkok
- University of Kuopio
- +12 more